<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04562649</url>
  </required_header>
  <id_info>
    <org_study_id>AAAT2430</org_study_id>
    <secondary_id>R01NR019758</secondary_id>
    <nct_id>NCT04562649</nct_id>
  </id_info>
  <brief_title>Community Health Worker And MHealth to ImProve Viral Suppression</brief_title>
  <acronym>CHAMPS</acronym>
  <official_title>Community Health Worker And MHealth to ImProve Viral Suppression</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Columbia University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Nursing Research (NINR)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Columbia University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The overall goal of this study is to evaluate the effects of the CHAMPS intervention for&#xD;
      people living with HIV (PLWH) in a randomized controlled trial. The proposed trial is&#xD;
      scientifically significant in representing a principled and systematic effort to test the&#xD;
      efficacy of a combined community health worker (CHW) and smartphone intervention linked to a&#xD;
      smart pill box for antiretroviral (ART) adherence in PLWH in the United States (US). Guided&#xD;
      by a rigorous theoretical model of supportive accountability and building on preliminary&#xD;
      work, this intervention has the potential to enable PLWH to self-manage their ART regimens&#xD;
      while CHW monitor their ART adherence in real-time ultimately leading to viral suppression&#xD;
      and ART adherence.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Persons living with HIV (PLWH) now achieve a near-normal life expectancy due to&#xD;
      antiretroviral therapy (ART) which has transformed HIV from a terminal diagnosis to a&#xD;
      manageable chronic condition. Despite widespread availability of ART in the United States&#xD;
      (US), many of the country's approximate 1.1 million PLWH are not fully benefitting from ART&#xD;
      due to poor adherence. These suboptimal HIV health outcomes occur at a time when clinicians&#xD;
      have limited time and the US healthcare system remains fragmented, further exacerbating the&#xD;
      challenges inherent in the lives of underserved, marginalized groups, such as PLWH.&#xD;
      Therefore, the development and evaluation of interventions using a cadre of community health&#xD;
      workers (CHW) holds promise for addressing these challenges in the US. This study addresses&#xD;
      limitations in current research on CHW interventions to improve viral suppression and ART&#xD;
      adherence. The investigators propose to build on strong preliminary data to strengthen a&#xD;
      community health worker (CHW) intervention using an existing mHealth approach, and provide&#xD;
      further information regarding the successful wide-scale implementation of this combination&#xD;
      intervention.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 3, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2024</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Viral Load</measure>
    <time_frame>Baseline, 6 month follow up, 12 month follow up</time_frame>
    <description>Using blood samples obtained during study visits, viral load levels will be used to asses ART adherence.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in ART adherence - CleverCap</measure>
    <time_frame>Up to 12 months</time_frame>
    <description>The CleverCapTM dispenser will automatically record each time a participant opens the dispenser. The investigators will collect adherence data each day from the start to the end of trial (day 1 to 12 months), and it is a count response (number of times taking medication each day).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Score on the Self-Rating Scale Item (SRSI)</measure>
    <time_frame>6 month follow up, 12 month follow up</time_frame>
    <description>The Self-Rating Scale Item is a single-item self-report adherence measure that uses a 5-point Likert scale to describe medication adherence over the past 4 weeks. Scores range from 1(very poor) to 6 (excellent).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>HIV/AIDS</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Wise App that delivers medication adherence reminders and community health worker sessions</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard of care</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Wise App with medication adherence reminders</intervention_name>
    <description>The Intervention group will receive the Wise App that delivers medication adherence reminders.</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>CHW Sessions</intervention_name>
    <description>The Intervention group will complete sessions with a community health worker (CHW).</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Be able to communicate and read in English or Spanish&#xD;
&#xD;
          -  Willing to participate in any assigned arm of the intervention&#xD;
&#xD;
          -  Diagnosed with HIV â‰¥6 months ago&#xD;
&#xD;
          -  Have an HIV-1 RNA level &gt;200 copies/mL, or have at least one &quot;no-show&quot; visit in the&#xD;
             past 12 months, or report being virally unsuppressed in the past 12 months&#xD;
&#xD;
          -  Have ART adherence &lt;80%, as measured through Single-Item Self-Rating Adherence Scale&#xD;
             (SRSI)&#xD;
&#xD;
          -  Own a smartphone&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Reside in a nursing home, prison, and/or receiving in-patient psychiatric care at time&#xD;
             of enrollment&#xD;
&#xD;
          -  Terminal illness with life expectancy &lt;6 months&#xD;
&#xD;
          -  Planning to move out of the area in the next 12 months&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rebecca Schnall, PhD, MPH, RN</last_name>
    <role>Principal Investigator</role>
    <affiliation>Columbia University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Rebecca Schnall, PhD, MPH, RN</last_name>
    <phone>212-342-6886</phone>
    <email>rb897@cumc.columbia.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Olivia Wood</last_name>
    <phone>212-305-8198</phone>
    <email>orw2104@cumc.columbia.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Birmingham AIDS Outreach</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35233</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emma Kay, PhD, MSW</last_name>
      <phone>205-322-4197</phone>
      <email>emma@mcwc-bao.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Alabama at Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35294</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Batey, PhD, MSW</last_name>
      <phone>205-934-5266</phone>
      <email>dsbatey@uab.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Columbia University Irving Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rebecca Schnall, PhD, MPH, RN</last_name>
      <phone>212-342-6886</phone>
      <email>rb897@cumc.columbia.edu</email>
    </contact>
    <contact_backup>
      <last_name>Olivia Wood</last_name>
      <phone>212-305-8198</phone>
      <email>orw2104@cumc.columbia.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>September 18, 2020</study_first_submitted>
  <study_first_submitted_qc>September 18, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 24, 2020</study_first_posted>
  <last_update_submitted>May 27, 2021</last_update_submitted>
  <last_update_submitted_qc>May 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Columbia University</investigator_affiliation>
    <investigator_full_name>Rebecca Schnall, RN, MPH, PhD</investigator_full_name>
    <investigator_title>Mary Dickey Lindsay Professor of Disease Prevention and Health Promotion</investigator_title>
  </responsible_party>
  <keyword>ART</keyword>
  <keyword>PLWH</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
    <mesh_term>HIV Infections</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

